| 发明名称 |
Cabozantinib Dosage Form and Use in the Treatment of Cancer |
| 摘要 |
This invention relates to a dosage form of cabozantinib and a method of employing the dosage form to treat cancer. |
| 申请公布号 |
US2016022662(A1) |
申请公布日期 |
2016.01.28 |
| 申请号 |
US201414782537 |
申请日期 |
2014.04.04 |
| 申请人 |
EXELIXIS, INC. |
发明人 |
DeCillis Arthur |
| 分类号 |
A61K31/47;A61K9/28;A61K9/00;A61K31/194 |
主分类号 |
A61K31/47 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical dosage comprising 60 mg, 40 mg, or 20 mg of compound 1: or a pharmaceutically acceptable salt thereof or a pharmaceutical composition comprising compound 1 and a pharmaceutically acceptable carrier. |
| 地址 |
South San Francisco CA US |
